Our results are relevant for future mechanistic studies (e.g., genetic, and pharmacological approaches) that will focus on understanding the role of hepatocytes and hepatic macrophages during TLR4-mediated proinflammatory episodes to create cell-specific therapeutical approaches in the IUGR newborn. This evidence concerns the gene TLR4 and fetal growth restriction.